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Multilocus sequence typing showed that the sequence type
obtained corresponded to ST512, an allelic single-locus variant of
the pandemic ST258 widely distributed in KPC producers from
Europe. To our knowledge, this is the ﬁrst report of KPC-3-
producing K. pneumoniae ST512 in a North African country.
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one of the major problems faced in hospitals worldwide [1].
Klebsiella pneumoniae that produce class A carbapenemases
(KPC) are frequently identiﬁed worldwide [2]. Here, we report
what to our knowledge is the ﬁrst case of infection byw Microbe and New Infect 2015; 3: 34–36
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p://dx.doi.org/10.1016/j.nmni.2014.09.001K. pneumoniae carrying the blaKPC gene isolated from a child in
the North African country of Algeria.
In June 2013, a 6-month-old child with hydrocephalus was
admitted to neurosurgery ward of Sétif University Hospital,
Algeria. After analysis of a cerebrospinal ﬂuid sample, a
K. pneumoniae isolate was isolated and identiﬁed using the API
20E identiﬁcation system (bioMérieux, Marcy l’Etoile, France)
and conﬁrmed by matrix-assisted laser desorption-ionization
time-of-ﬂight mass spectrometry (Microﬂex, Bruker Dal-
tonics, Bremen, Germany).
Antibiotic susceptibility testing performed using the disk
diffusion on Mueller-Hinton agar and Etest methods described by
the Antibiogram Committee of the French Society for Microbi-
ology (http://www.sfm-microbiologie.org/) showed that the
isolate was resistant to most antibiotics tested, including β-lac-
tams, aminoglycosides and ﬂuoroquinolones, with minimum
inhibitory concentrations against imipenem, ceftazidime, amikacin
and ciproﬂoxacin of 8 μg/mL, >256 μg/mL, 64 μg/mL and >32 μg/
mL, respectively. The isolate remained susceptible to tigecycline
and colistin with low minimum inhibitory concentrations (1 and
0.094 μg/mL, respectively). In order to identify the mechanism of
resistance to carbapenems, the isolate was screened for the
production of carbapenemase encoding genes using phenotypic
tests, including the modiﬁed Hodge test [3] and the CarbaNP test
[4], which were both positive. Metallo-β-lactamase activity per-
formed with the EDTA synergy method [3] was negative.
The presence of genes encoding for extended-spectrum
β-lactamases (blaCTX-M, blaTEM, blaSHV, blaPER, blaVEB) [5], KPCs
(blaKPC [6] and blaGES [7]), class D carbapenemases (blaOXA-48 [8]),
and metallo-β-lactamases (blaNDM-1 [5], blaIMP, blaVIM [9], blaSIM
[10], blaGIM [11]) was determined by standard PCR and sequencing.
Analysis of β-lactamase genes by PCR revealed the presence of
blaTEM, blaSHV and blaKPC genes. The nucleotides sequences of bla-
TEM, blaSHV and blaKPC genes, when compared to those on record in
the National Center for Biotechnology Information database,
showed a complete match with blaTEM-1, blaSHV-11 and blaKPC-3
genes, respectively. Screening for genes encoding aminoglycoside
modifying enzymes and 16S rRNA methylase genes demonstrated
that the isolate contained aac(60)-Ib and aadA genes.
Genotyping of the isolate was performed by multilocus
sequence typing (MLST) according to the Pasteur schemes
available at Institute Pasteur’s MLST Web site (http://www.
pasteur.fr/mlst). According to MLST analysis, the
K. pneumoniae isolate was attributed to sequence type (ST) 512
(allelic proﬁle: 54-3-1-1-1-1-79), an allelic single-locus variant of
the ST258.
To our knowledge, and according to data in the literature,
this is the ﬁrst report of a KPC-producing K. pneumoniae in
Algeria. KPC was ﬁrst described in North Carolina, USA, byEuropean Society of Clinical Microbiology and Infectious Diseases.
nses/by-nc-nd/3.0/)
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region in the world, including Europe, South America, the
Middle East [13] and Africa [14].
Carbapenemase-producing K. pneumoniae can cause life-
threatening infections, including bacteremia and pneumonia in
critically ill patients [15]. Currently, many studies described the
detection of K. pneumoniae isolates resistant to carbapenems in
children. These isolates may cause several infections in children,
including bloodstream, respiratory and urinary tract
infections [16].
In our study, carbapenem-resistant K. pneumoniae was also
isolated from a child. Our ﬁndings demonstrate that
K. pneumoniae resistant to carbapenems have become a serious
concern in pediatric care and has emerged in North Africa,
especially Algeria.
K. pneumoniae ST258 was the most frequently clone asso-
ciated with KPC-2 or KPC-3 enzyme production [16]. In late
2005, a carbapenem-resistant K. pneumoniae ST512, a single-
locus allelic variant of ST258, was identiﬁed in Israel [17]. In
the Mediterranean countries, outbreaks of KPC-producing
K. pneumoniae have been also reported [2]. In Italy, Pulcrano
et al. [16] reported an outbreak of a carbapenem-resistant
K. pneumoniae ST512 carrying the blaKPC-3, blaTEM and blaSHV
genes occurring between February 2011 and January 2012. In
our study, the K. pneumoniae isolated showed the same β-lac-
tamases and sequence type ST512.
In African countries, KPC producers were ﬁrst identiﬁed by
Brink et al. [14] in 2012, who reported the emergence of KPC-
2-producing K. pneumoniae in South Africa. To date, there is no
report describing the detection of KPC-producing
K. pneumoniae in the North African countries. In addition, to
our knowledge, the presence of the KPC enzyme in other
microorganisms was not described in Algeria and in other
North African countries. In Algeria, a recent study described
the detection of VIM metallo-β-lactamase-producing
K. pneumoniae [18], but none of the K. pneumoniae isolates that
produced KPC has been identiﬁed in this country.
Emergence of carbapenemase-producing K. pneumoniae with
a broad-spectrum antibiotic resistance proﬁle limits the anti-
microbial therapy options and poses difﬁculties for patient
treatment. The most active agents that can treat carbapenem-
resistant K. pneumoniae infections remain colistin and tigecy-
cline [15]. These two antibiotics may be a good therapeutic
option in such cases.
In summary, this report documents the emergence of KPC-3
among K. pneumoniae ST512 clinical isolate for the ﬁrst time in a
North African country, Algeria. Their prevalence may be
increasing in North African countries. However, more efforts to
control the spread of carbapenemase-producing K. pneumoniae
and surveillance measures are urgently needed in Algeria.New Microbes and New Infections © 2014 The Authors. Published by Elsevier Ltd on beha
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